Weizmannia coagulans BC99: A Breakthrough in Enhancing Human Strength and Muscle Quality

Recently, the Wecare Probiotics Research Institute has made a groundbreaking discovery regarding the benefits of Weizmannia coagulans BC99 in improving human strength, facilitating protein digestion, and increasing skeletal muscle content. The clinical research results, which have been published in the prestigious medical journal Nutrients, offer a novel solution for athletes and the elderly population to enhance their athletic performance and nutritional intake through the use of probiotics.

The latest clinical research findings on BC99 have garnered significant attention in the international arena, with the global authority in food science, NutraIngredients, also reporting on this innovation. On December 5th, NutraIngredients published an article titled "BC99 probiotic may improve strength and performance: Study", which has sparked widespread interest in the industry and underscored the international recognition of BC99.

The clinical study conducted by Wecare Probiotics involved 72 subjects aged 18-35 years, who had a fixed exercise training intensity. The subjects were randomly divided into a placebo group and a BC99 intervention group. After 12 weeks of intervention with Weizmannia coagulans BC99, the subjects in the intervention group exhibited significant improvements in their strength and body composition.

These positive effects were attributed to BC99's ability to enhance the digestion of intestinal proteins, promote the absorption of amino acids (the digestion products of proteins), and increase the anabolic effect on skeletal muscle. Additionally, BC99 improved the peripheral hormone levels and inflammatory responses related to skeletal muscle, thereby enhancing muscle quality.

The results indicate that BC99 has a positive impact on human strength and is conducive to improving skeletal muscle quality, promoting muscle protein synthesis, and reducing fat accumulation. BC99, isolated from the intestines of infants in Inner Mongolia, boasts application advantages such as high temperature resistance (≥100°C) and resistance to gastric acid and bile salts. Besides its probiotic benefits in sports nutrition, BC99 has also demonstrated remarkable efficacy in alleviating constipation, fighting Helicobacter pylori, facilitating protein digestion and absorption, detoxifying and protecting the liver, managing obesity, and relieving stress and anxiety. Its vast application prospects extend to various functional foods, dietary supplements, and pharmaceutical fields.

As a specialized and dedicated enterprise in probiotic strain research and a global supplier of probiotic raw materials, Wecare Probiotics has always adhered to the principle of technology-led development. The company has established professional probiotic research institutes in Suzhou, Wuhan, and Luohe, as well as a globally advanced probiotic smart manufacturing base. Wecare Probiotics is deeply engaged in scientific and evidence-based research on probiotic strains and has conducted in-depth clinical research collaborations with top medical and scientific research institutions such as Huashan Hospital of Fudan University, the Chinese People's Liberation Army General Hospital (301 Hospital), and APC Microbiome Ireland. These collaborations ensure that Wecare provides consumers with credible and efficacious probiotic strain application solutions.

Weizmannia coagulans BC99 represents a significant advancement in the field of probiotics, offering a promising option for improving human strength, muscle quality, and overall health. With its diverse benefits and robust scientific backing, BC99 holds immense potential for widespread application and benefit in various sectors.

References:
Cao L, Guo M, Zhou Y, et al. (2024). Weizmannia coagulans BC99 improves strength performance by enhancing protein digestion and regulating skeletal muscle quality in college students of physical education major. Nutrients, 16(23), 3990. https://doi.org/10.3390/nu16233990